AnVIL
NHGRI Analysis Visualizationand Informatics Lab-space
searchclose
TwitterYouYubeDiscourseGitHubSlack

Study

arrow_backDatasets

Center for Common Disease Genomics [CCDG] - Cardiovascular: The Bangladesh Risk of Acute Vascular Events (BRAVE) Study

CCDGphs001398.v1.p1dbGapdbGap FHIR

Description

The Bangladesh Risk of Acute Vascular Events (BRAVE) study is a hospital-based case-control study in Bangladesh which was established by the Cardiovascular Epidemiology Unit of Cambridge University in the UK in partnership with the key local cardiology and research centres to examine environmental, genetic, lifestyle and biochemical determinants of myocardial infarction (MI) among this South Asian population. By the end of 2016, this study has recruited ~8000 clinically confirmed first-ever MI cases (with a significant proportion being early-onset MI), and ~8000 healthy controls frequency-matched by age and sex. This site hosts data from ~500 whole genomes and ~1500 whole exomes (50% cases and 50% controls)

Stats

2Cohorts
1,992Samples
1,992Participants
8.81 TBSize

Summary

Consent CodesGRU
Diseasesmyocardial infarction
AccessControlled Access
Study DesignProspective Longitudinal Cohort
Data TypesWhole Genome, Exome

Terra Workspaces

This study has been divided into the following workspaces by consent codes and optionally the originating laboratory.

Terra Workspace NameConsent CodeDiseaseAccessStudy DesignData TypeSamplesParticipantsSize (TB)
AnVIL_CCDG_Broad_CVD_Stroke_BRAVE_WGSGRUmyocardial infarctionProspective Longitudinal CohortWhole Genome4964966.34
AnVIL_CCDG_Broad_MI_BRAVE_GRU_WESGRUmyocardial infarctionProspective Longitudinal CohortExome1,4961,4962.47